首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2084754

血管潰瘍治療市場：依疾病、藥物類別、通路和地區分類

Vascular Ulcers Treatment Market, By Disease Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2026年06月29日 | 出版商:

Coherent Market Insights | 英文 256 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，血管潰瘍治療市場規模將達到 33 億美元，到 2033 年將達到 46 億美元。預計從 2026 年到 2033 年，該市場將以 4.7% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	33億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.70%	2033年市場規模預測：	46億美元

血管性潰瘍是一種難以癒合或反覆發作的傷口或潰瘍。下肢和足部的潰瘍通常由心血管疾病或其他疾病引起。它們可以出現在膝蓋以下的小腿內側、足底或任何足部摩擦的部位。

在治療血管性潰瘍時，醫生可能會建議服用抗生素、清潔和處理傷口以及更換繃帶。他們也可能建議壓迫療法，即用彈性繃帶或彈性襪包裹患處。這種加壓療法可以促進血液循環並緩解症狀。

市場動態

市場相關人員正致力於提高公眾對心血管健康對創傷治療影響的認知，這有望在預測期內推動全球血管潰瘍治療市場的成長。例如，2020年2月3日，領先的先進創傷護理服務提供者Healogics Inc.啟動了第五屆心血管健康意識宣傳活動，旨在提高公眾對心血管健康和創傷治療之間關係的關注。在心血管健康宣導月期間，Healogics團隊成員通力合作，共同提升大眾對心血管疾病對創傷治療影響的認知。他們還解釋說，雖然區分動脈潰瘍和靜脈潰瘍有時可能比較困難，但準確的診斷有助於選擇最佳治療方案。

非營利組織在糖尿病領域的投入不斷增加，預計將鞏固其在全球血管潰瘍治療市場的地位。例如，2018年11月14日，美國醫學會（AMA）、疾病管制與預防中心（CDC）和廣告委員會聯合發起了「我是否患有糖尿病前期？」（Do I Have Pre-diabetes?）宣傳活動。該宣傳活動旨在傳遞一個令人鼓舞的訊息，強調美國成年人糖尿病前期的高發生率。新版宣傳活動運用幽默的情景，向觀眾展示他們身邊許多人可能患有糖尿病前期，並鼓勵他們進行簡單的線上風險評估測試，以了解自身狀況。

市場相關人員和非營利組織正透過收購和合作等策略拓展其全球業務，預計將推動全球血管潰瘍治療市場的成長。例如，2021年4月14日，英國的慈善基金會林賽腿部俱樂部基金會（LLCF）宣布與英國血管和傷口創傷護理服務提供者AD INTEGRUM Vascular & Wound Care達成一項創新合作協議。此次合作旨在提高人們對雙方共同目標的認知，即「為下肢疾病和潰瘍患者提供創傷護理，並確保他們擁有更高品質的生活」。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球血管潰瘍治療市場主要參與者的概況：公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要發展和策略以及未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球血管潰瘍治療市場」報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球血管潰瘍治療市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Bristol Myers Squibb Co.
- Sanofi
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- Cadila Pharmaceuticals Ltd.
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4639

Vascular Ulcers Treatment Market is estimated to be valued at USD 3.3 Bn in 2026 and is expected to reach USD 4.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.70%	2033 Value Projection:	USD 4.6 Bn

A vascular ulcer is a type of wound or sore that does not heal or returns repeatedly. Leg and foot ulcers are frequently caused by cardiovascular or other medical conditions. They can appear on the inside of your leg below the knee, the bottoms of your feet, or anywhere your feet rub together.

To treat vascular ulcers, the doctor may advise taking antibiotics or dressing, cleaning, and bandaging the wound. They may also advise to use compression therapy. This entails wrapping the affected area in a compression bandage or stocking. This pressure increases blood flow and alleviates symptoms.

Market Dynamics

Market players are focused on awareness programs related to impact of heart health on wound healing, which could contribute to the growth of the global vascular ulcers treatment market over the forecast period. For instance, on February 3, 2020, Healogics Inc., leading provider of advanced wound care services, conducted their fifth annual Heart Health Awareness campaign to bring attention to the concerns of heart health and wound healing. During Heart Health Awareness Month, members of the Healogics team collaborated to raise awareness about the impact of cardiovascular illnesses on wound healing. Also, it was explained how distinguishing between arterial and venous ulcers can be difficult, but a precise diagnosis can lead to the best treatment options.

Increasing initiatives by non-profit organizations related to diabetes is expected to strengthen their position in the global vascular ulcers treatment market. For instance, on November 14, 2018, The American Medical Association (AMA), the Centers for Disease Control and Prevention (CDC), and the Ad Council launched the Do I Have Pre-diabetes campaign, which features motivational messages emphasizing the prevalence of pre-diabetes in American adults. The newly updated campaign employs amusing scenarios to show viewers the many people in their lives who may have pre-diabetes and encourages them to take an easy online risk test to find out where they stand.

Market players and non-profit organizations are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, which is expected to drive the growth of the global vascular ulcers treatment market. For instance, on April 14, 2021, The Lindsay Leg Club Foundation (LLCF), a charitable foundation in the U.K., announced an innovative partnership agreement with AD INTEGRUM Vascular & Wound Care, a vascular and wound care service in England. The goal of this collaborative working partnership is to raise awareness of the fact that the two organizations are working towards the same goal: providing wound care and a better quality of life for people with lower limb conditions and leg ulcers.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global vascular ulcers treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Bristol Myers Squibb Co., Sanofi, Bayer AG, Pfizer Inc., Novo Nordisk A/S, and Cadila Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global vascular ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global vascular ulcers treatment market

Market Segmentation

By Disease Type (Revenue, USD Bn, 2021-2033)
Arterial Ulcers
Venous Ulcers
Neurotropic Ulcers
Diabetic Ulcers
Others
By Drug Class (Revenue, USD Bn, 2021-2033)
Antibiotics
Hemorrheologic Agents
Corticosteroids
Non-steroidal Anti-inflammatory Drug (NSAID)
Others
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Bristol Myers Squibb Co.
Sanofi
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
Cadila Pharmaceuticals Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Vascular Ulcers Treatment Market, By Disease Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Arterial Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Venous Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Neurotropic Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Diabetic Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Vascular Ulcers Treatment Market, By Drug Class, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Hemorrheologic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Non-steroidal Anti-inflammatory Drug (NSAID)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Vascular Ulcers Treatment Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Vascular Ulcers Treatment Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Bristol Myers Squibb Co.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cadila Pharmaceuticals Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views